Feature Channels:

Pharmaceuticals

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Circadian Clock

“Cyclops” Algorithm Spots Daily Rhythms in Cells

Humans, like virtually all other complex organisms on Earth, have adapted to their planet’s 24-hour cycle of sunlight and darkness. That circadian rhythm is reflected in human behavior, of course, but also in the molecular workings of our cells. Now scientists have developed a powerful tool for detecting and characterizing those molecular rhythms -- a tool that could have many new medical applications, such as more accurate dosing for existing medications.

Medicine

Channels:

Anaesthesia, global anesthesia, Malawi, Patient Safety, Surgery, safe surgery, Anesthesia, Lifebox, pulse oximeter, anesthesia training

Study Reveals How Lifebox Pulse Oximeters Lead to Patient Safety Improvement

A new report published today in the journal Anaesthesia reveals the positive impact of the donation of Lifebox pulse oximeters and training to patient safety in Malawi.

Medicine

Channels:

Mortality, Opioid Use Disorder, General Healthcare System

'Alarmingly High' Risk of Death for People with Opioid Use Disorder in General Medical Care

Almost one-fifth of patients with opioid use disorder (OUD) in a large healthcare system died during a four-year follow-up period, reports a study in the Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine (ASAM). The journal is published by Wolters Kluwer.

Medicine

Channels:

Immunotherapy, Maraba, non-small cell lung cancer

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 26-Apr-2017 3:00 AM EDT

Medicine

Channels:

Anesthesiology, Surgery, Opioids, Methadone, Pain Medicine, Postoperative Pain

Methadone May Reduce Need for Opioids After Surgery

Patients undergoing spinal fusion surgery who are treated with methadone during the procedure require significantly less intravenous and oral opioids to manage postoperative pain, reports a new study published in the May issue of Anesthesiology.

Medicine

Channels:

Preliminary Study Suggests Possible New Treatment for MS

A small, preliminary study may show promise of a new type of treatment for progressive multiple sclerosis (MS). Results from the first six people enrolled in the phase 1 study, a study designed to enroll 10 people, are being presented at the American Academy of Neurology’s 69th Annual Meeting in Boston, April 22 to 28, 2017.

Science

Channels:

Bladder Cancer, bladder cancer clinical trial, bladder cancer metastasis, bladder, bladder cancer treatment, atezolizumab, FDA Approval, FDA, FDA Cleared, bladder tumor, checkpoint inhibitors

NYU Langone Research Leads to Accelerated Approval of Bladder Cancer Immunotherapy Drug

Arjun-Balar-Patient-8.jpg

Findings from a clinical trial led by a researcher at NYU Langone’s Perlmutter Cancer Center helped pave the way for the recent, accelerated approval by the U.S. Food and Drug Administration (FDA) of a highly effective immunotherapy as first line treatment for patients with advanced bladder cancer who are not eligible for treatment with standard chemotherapy

Medicine

Channels:

Clinical Trial, Clinical Trials

The Medical Minute: Healthy Volunteers Vital to Clinical Trials

doctor_patient_2.jpg

There is an ongoing need for healthy volunteers in clinical research studies that can lead to healthcare breakthroughs that provide better drugs and treatments for patients.

Medicine

Channels:

Peer Reviewed Publication Confirms the Absence of Rhabdovirus in Cell Line Used for Manufacturing of Flublok®

/PRNewswire/ -- Protein Sciences Corporation is pleased to announce the publication of its manuscript entitled "Complete Study Demonstrating the Absence of Rhabdovirus in a Distinct Spodoptera frugiperda (Sf9) Cell Line" in the peer-reviewed journal PLOS ONE, Volume 12 issue 4. The publication follows extensive testing of the parent cells from which Protein Sciences' proprietary expresSF+® (SF+) cell line is derived. The study confirms that a contaminating rhabdovirus previously reported in a related cell line is not present in SF+ cells. These results demonstrate that not all cell lines are equal even if they are derived from the same parent cell line and highlight the high quality of the SF+ cell lineage.

Medicine

Channels:

150-Year-Old Drug May Provide ‘Off’ Time Relief for People with Advanced Parkinson’s Disease

New research provides evidence that an old drug may provide relief for people with advanced Parkinson’s, according to a study released today that will be presented at the American Academy of Neurology’s 69th Annual Meeting in Boston, April 22 to 28, 2017.







Chat now!